Journal of Photochemistry and Photobiology A Chemistry, Journal Year: 2024, Volume and Issue: unknown, P. 116163 - 116163
Published: Nov. 1, 2024
Journal of Photochemistry and Photobiology A Chemistry, Journal Year: 2024, Volume and Issue: unknown, P. 116163 - 116163
Published: Nov. 1, 2024
Journal of Biological Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 108164 - 108164
Published: Jan. 1, 2025
Lung cancer is the malignant tumor with highest morbidity and mortality rate worldwide, of which non-small cell lung (NSCLC) accounts for approximately 85%. KRAS mutations are one significant mechanisms underlying occurrence, development, immune escape, chemotherapy resistance NSCLC. Two inhibitors approved by FDA treatment NSCLC in past three years. However, they only effective to G12C mutant, moreover, innate acquired drug already reported, leaving an urgent need block pathways through novel targets. In this study, we focused on discovery ligands targeting RNA G-quadruplexes (RG4s) 5'-untranslated region (5'-UTR) mRNA, a tribenzophenazine analog (MBD) was identified as lead compound. Further were discussed A549/DDP cells, cisplatin-resistant KRAS-mutant line. Antitumor efficacy verified both vitro vivo nude mouse xenograft model implanted cells. To sum up, our results suggest potential MBD prominent anti-KRAS-driven agent, propose new idea development small molecule RG4s.
Language: Английский
Citations
0Bioorganic Chemistry, Journal Year: 2025, Volume and Issue: 160, P. 108446 - 108446
Published: April 8, 2025
Language: Английский
Citations
0Sensors and Actuators B Chemical, Journal Year: 2024, Volume and Issue: unknown, P. 136952 - 136952
Published: Nov. 1, 2024
Language: Английский
Citations
1Journal of Photochemistry and Photobiology A Chemistry, Journal Year: 2024, Volume and Issue: unknown, P. 116163 - 116163
Published: Nov. 1, 2024
Citations
0